CytomX Therapeutics CTMX Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $2.86M.
The official record: CytomX Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about CytomX Therapeutics's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CytomX Therapeutics's total debt?
- CytomX Therapeutics (CTMX) reported total debt of $2.86M in Q1 2026.
- How has CytomX Therapeutics's total debt changed year-over-year?
- CytomX Therapeutics's total debt decreased by 65.0% year-over-year, from $8.15M to $2.86M.
- What is the long-term trend for CytomX Therapeutics's total debt?
- Over 5 years (2020 to 2025), CytomX Therapeutics's total debt has grown at a -29.8% compound annual growth rate (CAGR), from $24.87M to $4.24M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.